Evidence from randomised trials on the long-term effects of hormone replacement therapy (Q34152308)

31 July 2017

1 reference

title

Evidence from randomised trials on the long-term effects of hormone replacement therapy (English)

1 reference

31 July 2017

1

Valerie Beral

1 reference

31 July 2017

3

Gillian Reeves

1 reference

31 July 2017

2

Emily Banks

1 reference

PubMed ID

12354487

31 July 2017

language of work or name

English

0 references

publication date

1 September 2002

1 reference

31 July 2017

1 reference

31 July 2017

360

1 reference

31 July 2017

9337

1 reference

31 July 2017

942-944

1 reference

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

31 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911032-4

7 January 2021

Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911032-4

7 January 2021

Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911032-4

7 January 2021

Noncardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911032-4

7 January 2021

Postmenopausal hormone therapy and risk of stroke: The Heart and Estrogen-progestin Replacement Study (HERS)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911032-4

7 January 2021

A clinical trial of estrogen-replacement therapy after ischemic stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911032-4

7 January 2021

Oestrogen and women's heart disease: ESPRIT-UK

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911032-4

7 January 2021

Design of the Women’s Health Initiative Clinical Trial and Observational Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911032-4

7 January 2021

Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Collaborative Group on Hormonal Factors in Breast Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911032-4

7 January 2021

Decreased risk of fractures of the hip and lower forearm with postmenopausal use of estrogen

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911032-4

7 January 2021

Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease: a randomized controlled trial. Alzheimer's Disease Cooperative Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911032-4

7 January 2021

Quality-of-life and depressive symptoms in postmenopausal women after receiving hormone therapy: results from the Heart and Estrogen/Progestin Replacement Study (HERS) trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911032-4

7 January 2021

Menopausal hormone replacement therapy and risk of ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911032-4

7 January 2021

10.1016/S0140-6736(02)11032-4

Identifiers

DOI

1 reference

31 July 2017

1 reference

PubMed ID

12354487